Associated Papers
Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
Seabrook AJ et al.
The Journal of Clinical Endocrinology and Metabolism, 2021
MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.
Walker CJ et al.
Journal of the National Cancer Institute, 2018
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma.
Wang D et al.
Nucleic Acids Research, 2017
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
Gibson WJ et al.
Nature Genetics, 2016
27348297 (PubMed )
Supplement: NIHMS791814-supplement-1.pdf
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
Chang MT et al.
Nature Biotechnology, 2016
26619011 (PubMed )
Supplement: NIHMS726517-supplement-2.pdf
Select a paper to view details